TRIL

Trillium Therapeutics Stock Price

6.84
-0.36 (-5.0%)
Upgrade to Real-Time
Regular Market
6.84

Low
5.74

52 Week Range

High
20.96

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Trillium Therapeutics Inc TRIL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.36 -5.0% 6.84 12:20:33
Open Price Low Price High Price Close Price Prev Close
7.23 6.72 7.23 7.20
Bid Price Ask Price Spread News
6.84 6.85 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,243 723,302 $ 6.95 $ 5,025,247 - 5.74 - 20.96
Last Trade Time Type Quantity Stock Price Currency
12:20:33 100 $ 6.84 USD

Period:

Draw Mode:

Trillium Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 606.60M 88.68M 12.35M $ 149.90k $ -140.79k -2.26 -4,308.56
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Trillium Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TRIL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.408.026.727.54761,388-0.56-7.57%
1 Month10.6110.746.728.46793,043-3.77-35.53%
3 Months9.6510.916.729.301,214,419-2.81-29.12%
6 Months12.9114.936.7210.351,337,259-6.07-47.02%
1 Year7.7620.965.7412.301,687,512-0.92-11.86%
3 Years5.4520.960.24056.981,415,2551.3925.5%
5 Years8.914420.960.24057.02892,434-2.07-23.27%

Trillium Therapeutics Description

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


Your Recent History
NASDAQ
TRIL
Trillium T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.